NTLA Stock Analysis: Buy, Sell, or Hold?
NTLA - Intellia Therapeutics, Inc
$13.15
-0.75 (-5.40%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When NTLA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
11 traders called NTLA this week
83% bullish • 2 bearish
83% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NTLA is down 10.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NTLA is down 10.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NTLA is currently trading at $13.15, which is considered slightly high relative to its 30-day fair value range of $9.42 to $13.64.
Technical Outlook: Technically, NTLA is in a downtrend. Immediate support is located at $11.70, while resistance sits at $17.09. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: NTLA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $23.86 (+71.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NTLA is in a downtrend. Immediate support is located at $11.70, while resistance sits at $17.09. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: NTLA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $23.86 (+71.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$9.42 -
$13.64
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.7%
Protect Your Profits
Holding NTLA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.4%)
- BULLISH: Trading 71.6% below Wall St target ($23.86)
- WARNING: Recommendation downgraded due to -10.1% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$9.42 -
$13.64
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$11.70
Resistance Level
$17.09
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.86
Wall Street Target
$23.86
(+71.6%)
Revenue Growth (YoY)
51.3%
Last updated: January 31, 2026 7:50 AM ET
Data refreshes hourly during market hours. Next update: 8:50 AM
Data refreshes hourly during market hours. Next update: 8:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTLA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Birgit C Schultes
SELL
31 shares
2025-10-01
Michael P Dube
SELL
1871 shares
2025-10-01
William J Chase
BUY
100000 shares
2025-08-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$65 | 60 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$42 | 53 HOLD |
Advanced NTLA Option Strategies
Professional options setups generated by AI based on today's NTLA price and gamma walls.
